Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DX25F6XTG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $43,114
Award facts
- Contract value 100% obligated
- $43,113.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units) on September 15, 2025. This firm fixed-price delivery order, valued at $43,113.50, represents a single procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The contract carries no set-aside designation, allowing the woman-owned small business to compete on a full-and-open basis. The pharmaceutical supplies will be delivered to the company's distribution facility in Park Ridge, Illinois, with an ultimate completion date of September 16, 2025.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler registered in the System for Award Management (SAM.gov) since 2001, serves as the prime contractor with no subcontractors identified. The company maintains a significant single-award IDC with the DLA under the SPE2DB program valued at $499 million through November 2026, positioning it as a critical supplier within the federal pharmaceutical supply chain. This delivery order for Xtandi, an oncology medication, exemplifies the company's role in distributing specialty pharmaceutical products to Department of Defense healthcare facilities nationwide.
Quick answers
Who was awarded contract SPE2DX25F6XTG?
SPE2DX25F6XTG was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 15, 2025.
How much is contract SPE2DX25F6XTG worth?
The government has obligated $43,114 on SPE2DX25F6XTG.
Is contract SPE2DX25F6XTG an order under another contract?
Yes. SPE2DX25F6XTG is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XTG competed?
The extent of competition for SPE2DX25F6XTG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award